QPPV.COM KNOWLEDGE ASSESSMENT

Knowledge Assessment: Estimating Patient Exposure in Pharmacovigilance

Test your understanding of the concepts covered by Estimating Patient Exposure in Pharmacovigilance.

Question 1 of 10Pass mark: 80%

Question 1 of 10 Which documentation practice best meets the need for reproducible exposure estimation?

Record only the final patient-year figure Document data sources, conversion factors, assumptions, calculations and quality review Rely on the experience of the report author without recording the rationale Document assumptions only when regulators request them

Question 2 of 10 For a fetal outcome analysis using a pregnancy registry, which denominator is generally most appropriate?

Number of exposed pregnancies Number of patient-years among all treated women Number of product packs distributed Number of women ever prescribed the medicine, regardless of pregnancy

Question 3 of 10 A regulator reviewing an exposure estimate is most likely to focus on which combination of qualities?

Mathematical precision without regard to data limitations Scientific credibility, appropriate metric selection, justified assumptions and methodological transparency The use of the most complex available statistical model Whether the estimate exactly equals the number of patients treated worldwide

Question 4 of 10 Which statement correctly describes the WHO Defined Daily Dose?

It is the legally recommended dose for every individual patient It is the actual dose received by each patient It is an assumed average maintenance dose per day for the principal adult indication It is a substitute for product-specific dosing information in all circumstances

Question 5 of 10 Which situation is an example of exposure double counting?

Using patient-years for a chronic therapy Counting product shipments from a manufacturer together with the receiving affiliate's sales of the same units Separating exposure by treatment indication Recalculating historical estimates after a justified methodology change

Question 6 of 10 Why may paediatric exposure estimates based solely on wholesale sales be unreliable?

Children always receive adult doses Age- and weight-dependent dosing, formulation changes and specialist supply channels may decouple product quantity from patient numbers Paediatric medicines are never dispensed through hospitals Sales data automatically identify each exposed child

Question 7 of 10 Why should patient-years based on average daily use be interpreted cautiously for an as-needed medicine?

As-needed medicines are always administered only once Individual use may range from occasional doses to prolonged frequent use, making average duration assumptions uncertain Patient-years cannot be used for any oral medicine As-needed use guarantees that sales equal administration

Question 8 of 10 For evaluation of immediate hypersensitivity after a vaccine, which exposure measure is generally most directly relevant?

Number of administered vaccine doses Number of patient-years since the vaccination programme began Number of doses manufactured worldwide Number of vaccinated countries

Question 9 of 10 What is the primary reason for independent quality review of exposure calculations?

To ensure that only the highest exposure estimate is selected To assess not only arithmetic accuracy but also data completeness, assumptions, units, reproducibility and unexpected trends To eliminate all uncertainty from post-marketing data To replace the scientific rationale with a standard spreadsheet

Question 10 of 10 Two patients each receive a medicine continuously for six months. How much patient-time exposure do they contribute in total?

0.5 patient-years 1 patient-year 2 patient-years 12 patient-years

QPPV.com

Knowledge Assessment: Estimating Patient Exposure in Pharmacovigilance

Cookie Settings